- Home
- EDU vs CORT Comparison
EDU vs CORT Comparison
Compare EDU & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDU
- CORT
- Stock Information
- Founded
- EDU 1993
- CORT 1998
- Country
- EDU China
- CORT United States
- Employees
- EDU N/A
- CORT N/A
- Industry
- EDU Other Consumer Services
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- EDU Real Estate
- CORT Health Care
- Exchange
- EDU Nasdaq
- CORT Nasdaq
- Market Cap
- EDU 7.3B
- CORT 7.1B
- IPO Year
- EDU 2006
- CORT N/A
- Fundamental
- Price
- EDU $48.64
- CORT $74.21
- Analyst Decision
- EDU Hold
- CORT Strong Buy
- Analyst Count
- EDU 4
- CORT 4
- Target Price
- EDU $48.50
- CORT $142.00
- AVG Volume (30 Days)
- EDU 1.2M
- CORT 1.4M
- Earning Date
- EDU 04-23-2025
- CORT 05-05-2025
- Dividend Yield
- EDU 1.19%
- CORT N/A
- EPS Growth
- EDU 27.46
- CORT 8.36
- EPS
- EDU 2.29
- CORT 1.14
- Revenue
- EDU $4,793,786,000.00
- CORT $685,446,000.00
- Revenue This Year
- EDU $13.92
- CORT $35.85
- Revenue Next Year
- EDU $13.49
- CORT $35.22
- P/E Ratio
- EDU $21.88
- CORT $64.25
- Revenue Growth
- EDU 18.73
- CORT 30.93
- 52 Week Low
- EDU $40.66
- CORT $25.35
- 52 Week High
- EDU $89.33
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- EDU 53.66
- CORT 56.46
- Support Level
- EDU $48.31
- CORT $68.86
- Resistance Level
- EDU $50.20
- CORT $73.36
- Average True Range (ATR)
- EDU 1.11
- CORT 3.16
- MACD
- EDU 0.15
- CORT 0.06
- Stochastic Oscillator
- EDU 59.33
- CORT 85.76
About EDU New Oriental Education & Technology Group Inc.
New Oriental is a prominent private education provider in China, offering a wide array of educational services. These include overseas test preparation, consulting services, high school academic tutoring, nonacademic tutoring, and intelligent learning systems and devices. Additionally, the company holds a 57% ownership stake in East Buy, a leading player in the livestreaming e-commerce market.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.